Literature DB >> 30637562

F18-choline/C11-choline PET/CT thyroid incidentalomas.

Francesco Bertagna1, Domenico Albano2, Luca Giovanella3, Raffaele Giubbini2, Giorgio Treglia3,4,5.   

Abstract

INTRODUCTION: Thyroid incidentaloma is defined as a thyroid lesion incidentally and newly detected by imaging techniques performed for an unrelated purpose and especially for a non-thyroid disease. Aim of this review is to evaluate the prevalence and clinical significance of focal incidental radiolabelled choline uptake in the thyroid gland (CTI) revealed by PET or PET/CT.
METHODS: A comprehensive computer literature search of the PubMed/MEDLINE, Scopus, and Embase databases was conducted to find relevant published articles about the prevalence and clinical significance of CTIs detected by PET or PET/CT in patients studied for other oncologic purposes.
RESULTS: Fifteen articles (14 case reports, one retrospective study on a larger population sample) were included in the systematic review. Considering the case reports, 7/14 CTIs were benign and 7/14 malignant. In the retrospective study on a larger population sample, 14/15 CTIs which underwent further investigations were benign.
CONCLUSION: Despite very rare but probably underestimated, CTIs frequently signal in the presence of unexpected lesions in the thyroid that differ from the indicated reason for which the patient was initially scanned, and the risk of malignancy is not negligible.

Entities:  

Keywords:  Choline; Incidental; PET/CT; Positron emission tomography; Thyroid; Thyroid incidentaloma

Year:  2019        PMID: 30637562     DOI: 10.1007/s12020-019-01841-z

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  30 in total

1.  Incidental detection of Hürthle cell adenoma by 18F-choline PET/CT scan in a patient with prostate cancer.

Authors:  G Paone; G Treglia; M Bongiovanni; T Ruberto; L Ceriani; L Giovanella
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2013-06-22       Impact factor: 1.359

2.  Oncocytic Adenoma of Thyroid Incidentally Detected by 18F-Fluorocholine PET/CT.

Authors:  Anne-Laure Aziz; Frederic Courbon; Lawrence O Dierickx; Pierre Pascal; Slimane Zerdoud
Journal:  J Nucl Med Technol       Date:  2015-04-09

3.  Incidental focal thyroid uptake on 18F-Choline PET-CT: need to rule out thyroid cancer.

Authors:  Renaud Ciappuccini; Corinne Jeanne; Stéphane Bardet
Journal:  Endocrine       Date:  2018-08-08       Impact factor: 3.633

4.  [Pitfalls with 18F-choline PET/CT in patients with prostate cancer].

Authors:  A M García Vicente; A Núñez García; A M Soriano Castrejón; G A Jiménez Londoño; J M Cordero García; A Palomar Muñoz
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2012-03-27       Impact factor: 1.359

5.  A thyroid incidentaloma detected by 18F-choline PET/CT.

Authors:  Giorgio Treglia; Elisabetta Giovannini; Paoletta Mirk; Davide Di Franco; Luigi Oragano; Francesco Bertagna
Journal:  Clin Nucl Med       Date:  2014-04       Impact factor: 7.794

6.  Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.

Authors:  M Picchio; C Messa; C Landoni; L Gianolli; S Sironi; M Brioschi; M Matarrese; D V Matei; F De Cobelli; A Del Maschio; F Rocco; P Rigatti; F Fazio
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

Review 7.  PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literature.

Authors:  Koen Mertens; Dominique Slaets; Bieke Lambert; Marjan Acou; Filip De Vos; Ingeborg Goethals
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-11       Impact factor: 9.236

8.  Dual Pathologies of Parathyroid Adenoma and Papillary Thyroid Cancer on Fluorocholine and Fluorodeoxyglucose PET/CT.

Authors:  N T K Thanseer; Sanjay Kumar Bhadada; Ashwani Sood; Ashwin Singh Parihar; Divya Dahiya; Priyanka Singh; Rajender Kumar Basher; Ashim Das; Bhagwant R Mittal
Journal:  Nucl Med Mol Imaging       Date:  2017-07-25

9.  Thyroid lymphoma incidentally detected by 18F-fluorocholine (FCH) PET/CT.

Authors:  Amy Eccles; Amarnath Challapalli; Sameer Khan; Tara Barwick; Stephen Mangar
Journal:  Clin Nucl Med       Date:  2013-09       Impact factor: 7.794

10.  Focal thyroid incidental uptake detected by ¹⁸F-fluorodeoxyglucose positron emission tomography. Meta-analysis on prevalence and malignancy risk.

Authors:  G Treglia; F Bertagna; R Sadeghi; F A Verburg; L Ceriani; L Giovanella
Journal:  Nuklearmedizin       Date:  2013-06-14       Impact factor: 1.379

View more
  5 in total

Review 1.  PET/CT in thyroid nodule and differentiated thyroid cancer patients. The evidence-based state of the art.

Authors:  Arnoldo Piccardo; Pierpaolo Trimboli; Luca Foppiani; Giorgio Treglia; Giulia Ferrarazzo; Michela Massollo; Gianluca Bottoni; Luca Giovanella
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

2.  Unusual uptakes on 18F-fluorocholine positron emission tomography/computed tomography (PET/CT): a retrospective study of 368 prostate cancer patients referred for a biochemical recurrence or an initial staging.

Authors:  Antoine Roland; Clément Drouet; Hatem Boulahdour; Alexandre Cochet; Berardino De Bari
Journal:  Quant Imaging Med Surg       Date:  2021-01

3.  Evaluation of Malignancy Risk in 18F-FDG PET/CT Thyroid Incidentalomas.

Authors:  Maria-Iulia Larg; Dragoș Apostu; Claudiu Peștean; Katalin Gabora; Iulian Claudiu Bădulescu; Elena Olariu; Doina Piciu
Journal:  Diagnostics (Basel)       Date:  2019-08-07

4.  The dilemma of 18F-FDG PET/CT thyroid incidentaloma: what we should expect from FNA. A systematic review and meta-analysis.

Authors:  Lorenzo Scappaticcio; Arnoldo Piccardo; Giorgio Treglia; David N Poller; Pierpaolo Trimboli
Journal:  Endocrine       Date:  2021-03-24       Impact factor: 3.633

5.  Prevalence of Brain Incidental Lesions Detected by 68Ga-DOTA Peptides PET/CT.

Authors:  Domenico Albano; Giorgio Treglia; Francesco Dondi; Francesco Bertagna
Journal:  Medicina (Kaunas)       Date:  2022-07-10       Impact factor: 2.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.